Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/320601 
Year of Publication: 
2020
Citation: 
[Journal:] Journal of Illicit Economies and Development (JIED) [ISSN:] 2516-7227 [Volume:] 2 [Issue:] 1 [Year:] 2020 [Pages:] 10-20
Publisher: 
LSE Press, London
Abstract: 
Access to controlled medications is problematic in many countries, in spite of the objectives of the international substance control conventions. The review describes barriers for accessing medications and how to assess the adequacy of opioid analgesic consumption globally. As current trends in consumption, it discusses the lack of progress of improving access and the threat of the false narrative that people who suffer moderate to severe pain are the cause of an epidemic of opioid intoxications. Finally, it questions the feasibility of an approach which requires large numbers of anaesthesiologist for treating chronic pain, and wonders what the effect of the COVID-19 pandemic on accessibility to controlled medications will be.
Subjects: 
Analgesics
Opioids
Pain Management
Health Policy
Needs Assessment
Persistent Identifier of the first edition: 
Creative Commons License: 
cc-by Logo
Document Type: 
Article

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.